Our Members

As a member-focused Association, our members are at the heart of everything we do at the PRI.

In principle any organization (public or private) is eligible to join the Association and become part of Europe’s growing microbiome-based medicinal product ecosystem.

Find out more about the different ways you and your organization can get involved with the PRI’s activities.

  • Microbiome Regulatory Science Support Work
  • Pre-competitive Task Groups
  • Year-round networking and project-related communication support

More than 100 PRI Members from 24 countries represent nearly every point along the microbiome science and development continuum, from fundamental research groups all the way to commercial manufacturing partners and pharmaceutical companies.

MaaT Pharma

MaaT Pharma

Eugenio Fernandez Alanis

Head of Regulatory Affairs

MaaT Pharma develops Microbiome Ecosystem Therapies to treat moderate to severe gut dysbiosis.

 

Mbiomics Gmbh

Mbiomics Gmbh

Laura Figulla

CEO and Co-Founder

 

 

Microba Life Sciences

Microba Life Sciences

Mark Parker

Global Business Development

Microba Life Sciences is a precision microbiome company powering discovery to improve human health by employing a human-first data-driven approach to identifying therapeutic leads.

 

Microbiome Insights

Microbiome Insights

Karl Moran

Head of Business Development and Sales

Microbiome Insights is focused on giving you a deeper understanding of functions and interactions of microbial communities—while never losing sight of the big picture. Our diverse, award-winning team brings together decades of experience in microbial ecology, microbiology, genomics, molecular genetics, and infectious diseases, providing the expertise you need to address all aspects of complex studies.

 

Microbiotica

Microbiotica

Adam Wilkinson

VP Pre-Clinical Development

Microbiome biomarker and drug development company with a world-leading microbiome analysis platform.

 

Milmed Unico AB

Milmed Unico AB

Tomas Lenz

CEO

We are an developer of Live Biotherapeutic Products. After 14 years of research the main objective is our development of regulated human LBP for treatment of allergic disorders, neurodegenerative diseases and inflammatory diseases. Our research and work has been rewarded, thus far, with two approved patents and a third patent pending to add to our growing patent family.

 

MRM Health NV

MRM Health NV

Selin Bolca

Director Pharmaceutical Development and Manufacturing

Unlocking the full potential of the gut microbiome for development of effective therapeutics through our proprietary CORAL™ consortia optimization and single-process manufacturing technology.

 

MyBiotics Pharma Ltd.

MyBiotics Pharma Ltd.

David Daboush

Co-Founder & CEO

MyBiotics is a clinical stage company that discovers and develops microbiome-based products aimed at restoring microbial equilibrium for the biopharmaceutical and supplement markets.